Direct access hybrid transatrial implantation of a Sapien 3 valve inside a bioprosthetic mitral valve with concomitant tricuspid valve replacement and cryoablation
- PMID: 34733705
- PMCID: PMC8505909
- DOI: 10.21037/acs-2021-tviv-17
Direct access hybrid transatrial implantation of a Sapien 3 valve inside a bioprosthetic mitral valve with concomitant tricuspid valve replacement and cryoablation
Conflict of interest statement
Conflicts of Interest: David H. Adams, MD: The Icahn School of Medicine at Mount Sinai receives royalty payments from Edwards Lifesciences and Medtronic for intellectual property related to development of valve repair rings. National Co-PI of the Medtronic APOLLO FDA Pivotal Trial, the NeoChord ReChord FDA Pivotal Trial, The Medtronic CoreValve US Pivotal Trial and the Abbott TRILUMINATE Pivotal Trial. Dr. Gilbert H. L. Tang: A physician proctor and consultant for Medtronic, a consultant for Abbott Structural Heart and NeoChord, and a physician advisory board member for Abbott Structural Heart and JenaValve. The other authors have no conflicts of interest to declare.
Figures
References
Publication types
LinkOut - more resources
Full Text Sources